Today's Top Gainer
Note:Top Gainer - Nifty 50 More
Dec 04,2019 12:58 PM
The inspection was conducted during the period 22nd July, 2019 to 26th July, 2019.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||439.25||40.24||105,246.83||823.16||0.63||3,215.01||98.33|
|Divis Laboratories Ltd||1,842.00||37.89||48,844.89||352.83||0.87||1,403.92||266.77|
|Dr Reddys Laboratories Ltd||2,821.50||18.65||46,904.85||1,365.10||0.71||3,435.30||852.70|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Shilpa Medicare Ltd., formerly known as Shilpa Antibiotics was incorporated as a private limited company in Nov.87 and has been promoted by Vishnukant C Bhutada and his associates. Shilpa Medicare Limited (SML) is engaged in the manufacturing of Active Pharmaceutical Ingredients (API), Formulation and Development service. The company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The company s... More
Dec 14, 2019 08:50 PM
The company’s consolidated revenue stood at Rs162.28cr, down 20.45% yoy and 18.11% qoq.
09 Nov 2019
31 Oct 2019
SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is sc... More
20 Sep 2019
29 Aug 2019
AGM 30/09/2019Dear Sir,In accordance with regulation 34 and other regulations of SEBI (Listing oblig... More
27 May 2019
12 Sep 2019
Shilpa Medicare Ltd has informed BSE that the Board of Directors of the Company at its Meeting held ... More